RESMED INC (RMD)

US7611521078 - Common Stock

215.01  +1.02 (+0.48%)

After market: 215.01 0 (0%)

Full estimates are only available for subscribed users, you can see which data is available below.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2021 2022 2023 2024 2025 2026 2027 2028 2029 2030
Revenue
YoY % growth
3.197B
8.11%		3.578B
11.93%		4.223B
18.02%		4.68B
10.82%
EBITDA
YoY % growth
1.074B
11.46%		1.16B
7.96%		1.317B
13.56%		1.545B
17.30%		N/AN/A
EBIT
YoY % growth
917.583M
13.42%		1B
9.01%		1.152B
15.17%		1.405B
21.96%
Operating Margin
28.70%27.96%27.28%30.02%
EPS
YoY % growth
5.33
11.97%		5.79
8.63%		6.45
11.40%		7.48
15.98%		N/AN/A

All data in USD

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
Q4 / 24 Q1 / 25 Q2 / 25 Q3 / 25 Q4 / 25
EPS
Q2Q % growth		1.98
23.54%
Revenue
Q2Q % growth		1.206B
7.48%
EBITDA
Q2Q % growth		404.65M
EBIT
Q2Q % growth		371.81M
29.90%

All data in USD

Recent Earnings VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q3 2024
Q2Q % growth		 2.13
26.79%		1.930.2010.24%
Q2 2024
Q2Q % growth		 1.88
13.25%		1.810.073.67%
Q1 2024
Q2Q % growth		 1.64
8.61%		1.630.010.42%
Q4 2023
Q2Q % growth		 1.60
7.38%		1.71-0.11-6.31%
Recent Revenue VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q2 2024
Q2Q % growth		 1.163B
12.48%		1.158B4.801M0.41%
Q1 2024
Q2Q % growth		 1.102B
16.00%		1.109B-6.679M-0.60%
Q4 2023
Q2Q % growth		 1.122B
22.66%		1.152B-29.943M-2.60%
Q3 2023
Q2Q % growth		 1.117B
29.20%		1.057B59.898M5.67%
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPS0.57% 3.27% -0.63% 2.57%
Revenue0.08% -0.51% -0.02% 0.28%